# GP Pharm SA – FDA Inspection, May 21, 2019

Source: https://www.keypedia.com/records/fda_inspections/gp-pharm-sa/9007b864-97a5-4e91-b3db-d9515b083a72
Source feed: FDA_Inspections

> FDA inspection 1091594 of GP Pharm SA, May 21, 2019. Classification: Official Action Indicated (OAI). 8 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091594
- Company Name: GP Pharm SA
- Inspection Date: 2019-05-21
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 8

## Related Documents

- FDA Inspection 1305252 - 2023-09-21
- FDA Inspection 1149441 - 2020-10-02
- FDA Inspection 1062872 - 2018-06-20
- [FDA Inspection 1004446 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/gp-pharm-sa/d67f0658-9a83-4622-a757-b6a1542990ad)
- FDA Inspection 917365 - 2015-01-27

## Related Officers

- [Cheryl A. Clausen](https://www.keypedia.com/people/cheryl-a-clausen/2306b2bc-8f01-4f77-ba2d-1a3186d6f6fc)
- Issuing Officer

Company: https://www.keypedia.com/companies/gp-pharm-sa/dc9c0e23-15fc-4984-99e1-68b6e5ad0899

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8